| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.06▲ | 2.05▲ | 2.05▲ | 2.04▲ | 1.84▲ |
| MA10 | 2.07▲ | 2.05▲ | 2.06▲ | 2.08▼ | 1.79▲ |
| MA20 | 2.06▲ | 2.06▲ | 2.04▲ | 1.86▲ | 2.07▲ |
| MA50 | 2.05▲ | 2.03▲ | 2.07▼ | 1.78▲ | 3.71▼ |
| MA100 | 2.06▲ | 2.08▼ | 1.93▲ | 2.06▲ | 4.47▼ |
| MA200 | 2.03▲ | 1.89▲ | 1.80▲ | 3.30▼ | 8.98▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.000▼ | 0.001▲ | 0.022▲ | 0.138▲ |
| RSI | 54.929▲ | 54.867▲ | 54.286▲ | 57.587▲ | 42.980▼ |
| STOCH | 25.824 | 49.954 | 37.222 | 58.064 | 51.319 |
| WILL %R | -64.286 | -40.909 | -46.667 | -30.792 | -40.157 |
| CCI | 39.195 | 73.590 | 60.455 | 48.944 | 39.716 |
|
Monday, April 28, 2025 05:00 PM
SOUTH SAN FRANCISCO, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced ...
|
|
Monday, April 28, 2025 01:00 PM
SOUTH SAN FRANCISCO, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced ...
|
|
Tuesday, April 22, 2025 05:00 PM
Nkarta (NKTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. SOUTH SAN ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/05/25 | 2.115 | 2.115 | 2.055 | 2.07 | 51,984 |
| 01/05/25 | 2.10 | 2.14 | 1.985 | 2.05 | 423,500 |
| 30/04/25 | 1.92 | 2.14 | 1.90 | 2.12 | 562,100 |
| 29/04/25 | 2.01 | 2.02 | 1.945 | 1.95 | 615,443 |
| 28/04/25 | 2.10 | 2.1599 | 1.98 | 2.01 | 651,288 |
| 25/04/25 | 2.15 | 2.15 | 2.045 | 2.11 | 452,793 |
| 24/04/25 | 2.16 | 2.21 | 2.095 | 2.20 | 498,300 |
| 23/04/25 | 2.28 | 2.28 | 2.07 | 2.18 | 925,966 |
| 22/04/25 | 1.89 | 2.25 | 1.89 | 2.22 | 1,774,386 |
| 21/04/25 | 1.78 | 1.9491 | 1.78 | 1.85 | 707,865 |
|
|
||||
|
|
||||
|
|